Comparison of three molecular methods for the detection and speciation of and -0

<p><b>Copyright information:</b></p><p>Taken from "Comparison of three molecular methods for the detection and speciation of and "</p><p>http://www.malariajournal.com/content/6/1/124</p><p>Malaria Journal 2007;6():124-124.</p><p>Published online 15 Sep 2007</p><p>PMCID:PMC2020467.</p><p></p>2% agarose at 100 v for 1 hour. B. (205-bp) and (120-bp) positive samples after 2round nested PCR, run on 2% agarose at 100 v for 1 hour. C. Real-time PCR melt curves of (74.5) and (78). Image provided by Optical Monitor Software v.3.1

Age-Specific Risk of Severe Disease in Patients Admitted with P. falciparum (Bold Line), P. vivax (Hashed Line), and Mixed (Dotted Line) Infections

<p>Lines represent predicted values from a logistic regression model in which age was entered as a linear effect, along with an interactive term for age and species.</p

Age Stratified Proportions of Hospital Patients with Malaria

<p>Bars represent proportion of all patients attending outpatients (A) or admitted to hospital (B) who were parasitaemic.</p

Age-Stratified Percentage of Females in Patients Hospitalised with P. falciparum (Squares) and P. vivax Infection (Diamonds)

<p>Error bars represent 95% CI, and dotted line denotes males and females present in equal proportions.</p

The Prevalence of Severe Disease in Patients Hospitalised with Malaria Stratified by Species of Infection and Age Group

<p>Severe disease defined by respiratory distress (RDS), coma, and SMA. For each age group the upper number above each column represents the total number of patients with severe disease (numerator), and the lower number is the total number of patients with the species of infection (denominator). Data on age were unavailable in 50 patients.</p

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria-0

<p><b>Copyright information:</b></p><p>Taken from "World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria"</p><p>http://www.biomedcentral.com/1475-2875/6/121</p><p>Malaria Journal 2007;6():121-121.</p><p>Published online 6 Sep 2007</p><p>PMCID:PMC2008207.</p><p></p>t four of the five sites where SP resistance was low or moderate, suggesting that this molecular marker could serve as a reliable surrogate for SP efficacy at these sites. Adapted from [12] with permission

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria-2

<p><b>Copyright information:</b></p><p>Taken from "World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria"</p><p>http://www.biomedcentral.com/1475-2875/6/121</p><p>Malaria Journal 2007;6():121-121.</p><p>Published online 6 Sep 2007</p><p>PMCID:PMC2008207.</p><p></p>t four of the five sites where SP resistance was low or moderate, suggesting that this molecular marker could serve as a reliable surrogate for SP efficacy at these sites. Adapted from [12] with permission